Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with parkinson's, alzheimer's with parkinsonism, and alzheimer's disease

Identifieur interne : 005363 ( Main/Exploration ); précédent : 005362; suivant : 005364

Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with parkinson's, alzheimer's with parkinsonism, and alzheimer's disease

Auteurs : Joyce [États-Unis] ; Gregory Smutzer [États-Unis] ; Christopher J. Whitty [États-Unis] ; Amanda Myers [États-Unis] ; Michael J. Bannon [États-Unis]

Source :

RBID : ISTEX:309B81976B938BA3645EDA245A6F6C526D544AFC

English descriptors

Abstract

The molecular characteristics of midbrain dopamine (DA) neurons have been extensively studied in Parkinson's disease (PD). No such studies of the characteristics of midbrain DA neurons in Alzheimer's disease (AD) or Alzheimer's disease with parkinsonism (AD/Park) have been published. We examined the levels of tyrosine hydroxylase (TH) protein, and the expression of TH and dopamine transporter (DAT) mRNAs, in midbrain neurons of PD, AD, and AD/Park cases. In PD, the loss of TH protein in the ventral tier of the substantia nigra pars compacta (SNpc) of the PD group is accompanied by severe losses in the number of neurons that express TH mRNA and DAT mRNA (74% loss). Remaining neurons show a shift to higher concentrations of TH mRNA but a shift to lower concentrations of DAT mRNA per cell. Hence, there is evidence that compensation in the remaining neurons can elevate concentrations of TH mRNA and lower DAT mRNA. Alternatively, there may be a predilection for a loss of neurons with high levels of DAT mRNA and low TH mRNA levels within the SNpc of PD cases. There was no change in TH protein but an elevation of TH mRNA concentrations per neuron without any change in concentrations of DAT mRNA in the AD group. The AD/Park group did not exhibit changes in the level of TH protein, but showed a small loss (26%) of neurons in the SNpc and a greater loss in other regions of the midbrain (43–53%). Remaining DA neurons showed a marked shift to lower concentrations of DAT mRNA per neuron and a nonsignificant shift in cellular concentration of TH mRNA to higher levels. This is consistent with our previous work showing that with AD/Park there is a significant reduction in the number of DAT sites located on DA terminals in the striatum, but the midbrain neurons have not died. Our results indicate that the differential regulation of mRNAs encoding TH and DAT is similar in the parkinsonian disorders (PD and AD/Park) even though the degree of cell death is very different. This might suggest that compensatory events occur in these DA neurons in AD/Park that are similar to those in PD and that result in differential effects on mRNAs encoding TH and DAT proteins.

Url:
DOI: 10.1002/mds.870120609


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with parkinson's, alzheimer's with parkinsonism, and alzheimer's disease</title>
<author>
<name sortKey="Joyce" sort="Joyce" uniqKey="Joyce" last="Joyce">Joyce</name>
</author>
<author>
<name sortKey="Smutzer, Gregory" sort="Smutzer, Gregory" uniqKey="Smutzer G" first="Gregory" last="Smutzer">Gregory Smutzer</name>
</author>
<author>
<name sortKey="Whitty, Christopher J" sort="Whitty, Christopher J" uniqKey="Whitty C" first="Christopher J." last="Whitty">Christopher J. Whitty</name>
</author>
<author>
<name sortKey="Myers, Amanda" sort="Myers, Amanda" uniqKey="Myers A" first="Amanda" last="Myers">Amanda Myers</name>
</author>
<author>
<name sortKey="Bannon, Michael J" sort="Bannon, Michael J" uniqKey="Bannon M" first="Michael J." last="Bannon">Michael J. Bannon</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:309B81976B938BA3645EDA245A6F6C526D544AFC</idno>
<date when="1997" year="1997">1997</date>
<idno type="doi">10.1002/mds.870120609</idno>
<idno type="url">https://api.istex.fr/document/309B81976B938BA3645EDA245A6F6C526D544AFC/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000079</idno>
<idno type="wicri:Area/Istex/Curation">000079</idno>
<idno type="wicri:Area/Istex/Checkpoint">003987</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Joyce:differential:modification:of</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:9399211</idno>
<idno type="wicri:Area/PubMed/Corpus">004570</idno>
<idno type="wicri:Area/PubMed/Curation">004570</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004674</idno>
<idno type="wicri:Area/Ncbi/Merge">004E15</idno>
<idno type="wicri:Area/Ncbi/Curation">004E15</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004E15</idno>
<idno type="wicri:doubleKey">0885-3185:1997:Joyce J:differential:modification:of</idno>
<idno type="wicri:Area/Main/Merge">008392</idno>
<idno type="wicri:Area/Main/Curation">005363</idno>
<idno type="wicri:Area/Main/Exploration">005363</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with parkinson's, alzheimer's with parkinsonism, and alzheimer's disease</title>
<author>
<name sortKey="Joyce" sort="Joyce" uniqKey="Joyce" last="Joyce">Joyce</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Thomas H. Christopher Center for Parkinson's Disease Research, Sun Health Research Institute, Sun City, Arizona</wicri:regionArea>
<placeName>
<region type="state">Arizona</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Smutzer, Gregory" sort="Smutzer, Gregory" uniqKey="Smutzer G" first="Gregory" last="Smutzer">Gregory Smutzer</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania</wicri:regionArea>
<placeName>
<region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Whitty, Christopher J" sort="Whitty, Christopher J" uniqKey="Whitty C" first="Christopher J." last="Whitty">Christopher J. Whitty</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychiatry, Wayne State University, Detroit, Michigan</wicri:regionArea>
<placeName>
<region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Myers, Amanda" sort="Myers, Amanda" uniqKey="Myers A" first="Amanda" last="Myers">Amanda Myers</name>
<affiliation wicri:level="4">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Anatomy–Neurobiology, Washington University School of Medicine, St. Louis, Missouri</wicri:regionArea>
<placeName>
<region type="state">Missouri (État)</region>
<settlement type="city">Saint-Louis (Missouri)</settlement>
</placeName>
<orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName>
</affiliation>
</author>
<author>
<name sortKey="Bannon, Michael J" sort="Bannon, Michael J" uniqKey="Bannon M" first="Michael J." last="Bannon">Michael J. Bannon</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Psychiatry, Wayne State University, Detroit, Michigan</wicri:regionArea>
<placeName>
<region type="state">Michigan</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1997-11">1997-11</date>
<biblScope unit="vol">12</biblScope>
<biblScope unit="issue">6</biblScope>
<biblScope unit="page" from="885">885</biblScope>
<biblScope unit="page" to="897">897</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">309B81976B938BA3645EDA245A6F6C526D544AFC</idno>
<idno type="DOI">10.1002/mds.870120609</idno>
<idno type="ArticleID">MDS870120609</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aged</term>
<term>Alzheimer Disease (complications)</term>
<term>Alzheimer Disease (pathology)</term>
<term>Alzheimer's disease</term>
<term>Biological Transport</term>
<term>Cell Count</term>
<term>Cloning, Molecular</term>
<term>Culture Techniques</term>
<term>Dopamine</term>
<term>Dopamine (genetics)</term>
<term>Dopamine (metabolism)</term>
<term>Female</term>
<term>Humans</term>
<term>In Situ Hybridization</term>
<term>Male</term>
<term>Mesencephalon (metabolism)</term>
<term>Middle Aged</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (pathology)</term>
<term>Parkinson's disease</term>
<term>Parkinsonism</term>
<term>RNA, Messenger (metabolism)</term>
<term>Substantia Nigra (metabolism)</term>
<term>Substantia nigra</term>
<term>Tyrosine</term>
<term>Tyrosine 3-Monooxygenase (genetics)</term>
<term>Tyrosine 3-Monooxygenase (metabolism)</term>
<term>mRNAs</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Dopamine</term>
<term>Tyrosine 3-Monooxygenase</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en">
<term>Alzheimer Disease</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Dopamine</term>
<term>Mesencephalon</term>
<term>RNA, Messenger</term>
<term>Substantia Nigra</term>
<term>Tyrosine 3-Monooxygenase</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Alzheimer Disease</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Aged</term>
<term>Biological Transport</term>
<term>Cell Count</term>
<term>Cloning, Molecular</term>
<term>Culture Techniques</term>
<term>Female</term>
<term>Humans</term>
<term>In Situ Hybridization</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The molecular characteristics of midbrain dopamine (DA) neurons have been extensively studied in Parkinson's disease (PD). No such studies of the characteristics of midbrain DA neurons in Alzheimer's disease (AD) or Alzheimer's disease with parkinsonism (AD/Park) have been published. We examined the levels of tyrosine hydroxylase (TH) protein, and the expression of TH and dopamine transporter (DAT) mRNAs, in midbrain neurons of PD, AD, and AD/Park cases. In PD, the loss of TH protein in the ventral tier of the substantia nigra pars compacta (SNpc) of the PD group is accompanied by severe losses in the number of neurons that express TH mRNA and DAT mRNA (74% loss). Remaining neurons show a shift to higher concentrations of TH mRNA but a shift to lower concentrations of DAT mRNA per cell. Hence, there is evidence that compensation in the remaining neurons can elevate concentrations of TH mRNA and lower DAT mRNA. Alternatively, there may be a predilection for a loss of neurons with high levels of DAT mRNA and low TH mRNA levels within the SNpc of PD cases. There was no change in TH protein but an elevation of TH mRNA concentrations per neuron without any change in concentrations of DAT mRNA in the AD group. The AD/Park group did not exhibit changes in the level of TH protein, but showed a small loss (26%) of neurons in the SNpc and a greater loss in other regions of the midbrain (43–53%). Remaining DA neurons showed a marked shift to lower concentrations of DAT mRNA per neuron and a nonsignificant shift in cellular concentration of TH mRNA to higher levels. This is consistent with our previous work showing that with AD/Park there is a significant reduction in the number of DAT sites located on DA terminals in the striatum, but the midbrain neurons have not died. Our results indicate that the differential regulation of mRNAs encoding TH and DAT is similar in the parkinsonian disorders (PD and AD/Park) even though the degree of cell death is very different. This might suggest that compensatory events occur in these DA neurons in AD/Park that are similar to those in PD and that result in differential effects on mRNAs encoding TH and DAT proteins.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Arizona</li>
<li>Michigan</li>
<li>Missouri (État)</li>
<li>Pennsylvanie</li>
</region>
<settlement>
<li>Saint-Louis (Missouri)</li>
</settlement>
<orgName>
<li>École de médecine (Université Washington de Saint-Louis)</li>
</orgName>
</list>
<tree>
<country name="États-Unis">
<region name="Arizona">
<name sortKey="Joyce" sort="Joyce" uniqKey="Joyce" last="Joyce">Joyce</name>
</region>
<name sortKey="Bannon, Michael J" sort="Bannon, Michael J" uniqKey="Bannon M" first="Michael J." last="Bannon">Michael J. Bannon</name>
<name sortKey="Myers, Amanda" sort="Myers, Amanda" uniqKey="Myers A" first="Amanda" last="Myers">Amanda Myers</name>
<name sortKey="Smutzer, Gregory" sort="Smutzer, Gregory" uniqKey="Smutzer G" first="Gregory" last="Smutzer">Gregory Smutzer</name>
<name sortKey="Whitty, Christopher J" sort="Whitty, Christopher J" uniqKey="Whitty C" first="Christopher J." last="Whitty">Christopher J. Whitty</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005363 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005363 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:309B81976B938BA3645EDA245A6F6C526D544AFC
   |texte=   Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with parkinson's, alzheimer's with parkinsonism, and alzheimer's disease
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024